Tci Wealth Advisors, Inc. Amicus Therapeutics, Inc. Transaction History

Tci Wealth Advisors, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$10.91 - $13.54 $4,047 - $5,023	-371 Reduced 35.78%	666 $7,000
Q4 2022 Feb 06, 2023	BUY	$9.89 - $12.7 $3,669 - $4,711	371 Added 55.71%	1,037 $12,000
Q2 2022 Jul 19, 2022	BUY	$6.23 - $11.12 $230 - $411	37 Added 5.88%	666 $7,000
Q1 2022 Apr 29, 2022	BUY	$7.89 - $12.48 $4,962 - $7,849	629 New	629 $6,000
Q4 2021 Jan 24, 2022	SELL	$9.82 - $12.44 $5,126 - $6,493	-522 Closed	0 $0
Q3 2021 Oct 29, 2021	SELL	$8.74 - $11.84 $734 - $994	-84 Reduced 13.86%	522 $5,000
Q2 2021 Aug 02, 2021	BUY	$8.71 - $10.72 $5,278 - $6,496	606 New	606 $6,000

311

312M

516K

833K

Ticker FOLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 280,497,984
Market Cap $2.69B
Description
Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.